Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07569900Recruiting
Testing a new gonorrhea test for women
This study evaluates a new rapid test for gonorrhea designed for women. You'll provide vaginal swab samples and complete a brief counseling session to help researchers understand how well the test works and whether patients can use it correctly.
Johannesburg, GautengAges 16 years+ - NCT07338838RecruitingPhase 1
Testing TQB3142 in advanced tumors
This trial tests a new drug called TQB3142 in people with advanced cancers that have not responded to standard treatments. The goal is to find a safe dose and see how the drug works in the body.
Guangzhou, GuangdongAges 18–75 - NCT07338786Enrolling by invitationPhase 1
Rabies vaccine safety trial for ages 10 to 60
This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.
Xuzhou, JiangsuAges 10–60 - NCT07335601RecruitingPhase 2
Resmetirom for liver health after transplant in MASH patients
This trial tests an experimental drug, resmetirom, to see if it can help people who have had a liver transplant for MASH and now have fatty buildup in their new liver. It may also help people who had a transplant for other reasons but developed fatty liver afterward. The study focuses on those with moderate to advanced liver scarring (F2-F3).
La Jolla, CaliforniaAges 18–75 - NCT07100210RecruitingPhase 1
Study of a new drug for advanced solid tumors that haven't responded to treatment
This trial tests a new drug, IL-22BP/LNP, for people with advanced solid tumors (like soft tissue sarcoma, head and neck cancer, melanoma) that have worsened after standard treatments. The main goals are to see if the drug is safe and tolerable, and to learn if it might help shrink or slow the cancer.
Chengdu, SichuanAges 18–70 - NCT06497244Recruiting
Micro-holes in bone to speed molar movement
This trial tests whether tiny holes made in the bone (micro-osteoperforation) can speed up moving your upper back molars backward using a device anchored to bone. It is for adults with a specific bite problem (Class II on both sides) who are healthy and have all their teeth.
CairoAges 16 years+ - NCT07105254RecruitingPhase 2
Roflumilast foam study for children with vitiligo
This study tests a medicated foam (Roflumilast) in children with non-segmental vitiligo to see if it can improve skin color on the face and body. It is for patients aged 2 to 17 with small patches and at least some pigmented hair in the face patches.
Dallas, TexasAges 2–18 - NCT07091422Recruiting
Testing a new brace glue: does it hold better?
This trial tests a new no-etching glue for braces. Half of your mouth will get the new glue, the other half a standard glue, to see which one holds the brackets better over a year.
Baltimore, MarylandAges 14–35 - NCT07156903Recruiting
Understanding patient and caregiver needs during prostate cancer radiation
This study asks people with prostate cancer and their caregivers about their needs during and after radiation treatment. It uses interviews to learn how to better support patients and families.
BerlinAges 18 years+ - NCT05589220Recruiting
Music and nicotine patches to reduce cravings in student smokers
This study tests whether combining music therapy with nicotine replacement (like a patch or gum) can reduce smoking cravings when students try to quit. It’s aimed at motivated students who smoke regularly and want help with quitting.
PoitiersAges 18–25 - NCT07154121Recruiting
5-FU added to tear duct surgery for small tear sacs
This study tests if adding a medicine called 5-FU to standard tear duct surgery helps people with a small tear drainage sac get better results. It might be an option if you have a blocked tear duct and a very small sac.
Guangzhou, GuangdongAges 18 years+ - NCT07321574RecruitingPhase 2
Testing ABP1011T for advanced solid tumors
This trial tests an experimental pill called ABP1011T for people with advanced solid tumors that are no longer responding to standard treatments. It is especially focused on small cell lung cancer and other cancers that might be sensitive to this drug. The goal is to see if the pill can shrink tumors or slow their growth.
Luoyang, HenanAges 18–75 - NCT06549465RecruitingPhase 2
Ac-225 rosopatamab for PSMA-positive castration-resistant prostate cancer
This trial tests a radioactive drug (Ac-225 rosopatamab tetraxetan) that targets a protein called PSMA on prostate cancer cells. It is for patients whose cancer has stopped responding to hormone therapy and has spread to other parts of the body.
San Diego, CaliforniaAges 18 years+ - NCT07186426RecruitingPhase 3
Testing HSK21542 for pain after hip replacement surgery
This trial tests a new pain medicine called HSK21542 for people who have hip replacement surgery under general anesthesia. It aims to see if the drug can safely reduce moderate to severe pain after surgery.
Beijing, Beijing MunicipalityAges 18–74 - NCT07185243Recruiting
Study of virus injection plus immunotherapy for advanced solid tumors
This study tests a new combination treatment: a modified virus (hV01) injected directly into a tumor, plus a drug that helps your immune system attack cancer cells (PD-1 inhibitor). It is for people with advanced solid tumors that have not responded to standard therapies.
Xiamen, FujianAges 18–75 - NCT06493357Recruiting
Improving HIV testing and care for mothers and babies in Malawi
This study is testing a new way to find and treat HIV in pregnant women and new mothers in Malawi. It may help prevent passing HIV from mother to baby.
Lilongwe, Central RegionAges 16 years+ - NCT07073430Recruiting
AI tool to help diagnose precancerous colon polyps
This trial tests an artificial intelligence system that helps doctors find and diagnose tubular adenomas (a type of precancerous polyp) during colonoscopy. It may improve early detection of colorectal cancer.
Wuhan, HubeiAges 18 years+ - NCT07043998Recruiting
Comparing two ways to cement porcelain-fused-to-metal crowns
This study tests two different ways of using a special cement to attach porcelain-fused-to-metal crowns. It aims to see which curing method works best to keep your new crown strong and secure.
CairoAges 21 years+ - NCT07552805Recruiting
Home monitoring device after major digestive surgery
This study tests a wearable patch called Multisense that monitors your health at home after major gastrointestinal surgery. It's designed to catch problems early so you can stay safe and avoid returning to the hospital.
Nice, Alpes-MaritimesAges 18 years+ - NCT06484868RecruitingPhase 4
Study of metreleptin for partial lipodystrophy
This trial tests an open-label study of metreleptin in people with partial lipodystrophy, a condition where fat is lost from some areas of the body. The goal is to see if the drug can help manage related health problems.
LilleAges 12 years+ - NCT07387068RecruitingPhase 1
Testing GEN1079 for advanced solid tumors
This trial tests an experimental drug called GEN1079 for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if it's safe and if it helps shrink tumors.
New Haven, ConnecticutAges 18 years+ - NCT07510412Recruiting
NuShield plus standard care for venous leg ulcers
This trial tests a new wound covering called NuShield, used with standard care, to help heal leg ulcers caused by poor vein circulation. It may be an option if your ulcer hasn't healed after standard treatment.
Pickerington, OhioAges 18 years+ - NCT07147049RecruitingPhase 2
Testing a new painkiller for moderate to severe pain after surgery
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
Chengdu, SichuanAges 18–75 - NCT07520565RecruitingPhase 3
Emergency stroke treatment with BXOS110 within 3 hours
This trial tests whether BXOS110, an experimental injection, can help people recover better after an acute ischemic stroke (a stroke caused by a blood clot) when given within 3 hours of symptom onset. The study compares BXOS110 to a placebo to see if it reduces disability and improves recovery.
Hengshui, HebeiAges 18–85
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.